Empagliflozin S-Furanose
Synchemia is a leading supplier in pharmaceutical Empagliflozin Impurities . Empagliflozin (brand name Jardiance) is a prescription medication used to manage conditions such as diabetes, heart failure, and kidney disease.
Empagliflozin S-Furanose CAS NO: 1620758-32-8 chemically represented as (2S,3R,4R,5R)-2-(4-Chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-5-((R)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol . Empagliflozin S-Furanose is supplied with comprehensive characterization data, in full compliance with applicable regulatory guidelines. Synchemia is the leading supplier and exporter of Empagliflozin S-Furanose . All Synchemia products are strictly intended for analytical testing purposes only and not for human use.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-E39009 |
| CAS No | NA |
| Mol.F. | C23H29ClO8 |
| Mol.Wt. | 468.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39010 |
| CAS No | 2137418-13-2 |
| Mol.F. | C23H27ClO8 |
| Mol.Wt. | 466.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39011 |
| CAS No | 96-48-0 |
| Mol.F. | C4H6O2 |
| Mol.Wt. | 86.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39012 |
| CAS No | 86087-24-3 |
| Mol.F. | C4H8O2 |
| Mol.Wt. | 88.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39013 |
| CAS No | 86087-23-2 |
| Mol.F. | C4H8O2 |
| Mol.Wt. | 88.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39014 |
| CAS No | 887510-13-6 |
| Mol.F. | C10H12O4S |
| Mol.Wt. | 228.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39015 |
| CAS No | NA |
| Mol.F. | C34H32Cl2O4 |
| Mol.Wt. | 575.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39016 |
| CAS No | NA |
| Mol.F. | C27H31ClO9 |
| Mol.Wt. | 535g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39017 |
| CAS No | NA |
| Mol.F. | C22H27ClO8 |
| Mol.Wt. | 454.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39018 |
| CAS No | NA |
| Mol.F. | C1713C6H27ClO7 |
| Mol.Wt. | 456.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39019 |
| CAS No | NA |
| Mol.F. | C29H35ClO13 |
| Mol.Wt. | 627g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39020 |
| CAS No | NA |
| Mol.F. | C29H35ClO13 |
| Mol.Wt. | 627g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39021 |
| CAS No | NA |
| Mol.F. | C29H35ClO13 |
| Mol.Wt. | 627g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39022 |
| CAS No | NA |
| Mol.F. | C29H35ClO13 |
| Mol.Wt. | 627g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39023 |
| CAS No | NA |
| Mol.F. | C25H31ClO9 |
| Mol.Wt. | 511g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39024 |
| CAS No | NA |
| Mol.F. | C23H27ClO7 |
| Mol.Wt. | 450.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |